Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data

Recruiting now

Conditions studied: Pancreatic Cystic Lesion, Mucinous Cystadenoma of Pancreas, Intraductal Papillary Mucinous Neoplasm of Pancreas, Pseudocyst Pancreas, Serous Cystadenoma, Neuroendocrine Tumors, NET

In brief

The primary objective is to construct a multimodal AI model (Cyst-AI) based on EUS images and clinical data such as imaging features(CT or MRI) and laboratory tests to assist endoscopists in the diagnosis of pancreatic cystic lesions(PCLs), mainly differentiating mucinous from non-mucinous lesions. The secondary objective is to evaluate the model's effectiveness in risk stratification and clinical management for patients with PCLs.

Key facts

Study ID
NCT07463872
Run by
Huazhong University of Science and Technology
People needed
500
Starts
2025-01-01
Expected to finish
2026-06-01
Last updated by the study team
2026-03-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.